(MENAFN- GlobeNewsWire - Nasdaq) Key drivers include increasing maternal age, technological innovations, heightened awareness, and a strong healthcare infrastructure enabling early and accurate genetic screening. While urban centers enjoy widespread access, challenges persist due to costs and rural availability. Continued advancements and public awareness are anticipated to further expand the NIPT market in Australia.

Dublin, Nov. 05, 2025 (GLOBE NEWSWIRE) -- The "Australia Non-Invasive Prenatal Testing Market Size and Share Analysis - Growth Trends and Forecast Report 2025-2033" has been added to ResearchAndMarkets's offering.
The Australia Non-Invasive Prenatal Testing Market is expected to reach US$ 218.3 million by 2033 from US$ 71.41 million in 2024, with a CAGR of 13.22% from 2025 to 2033. Rising maternal age, technical developments, more knowledge, and a robust healthcare system that supports early and precise genetic screening choices are the main factors propelling Australia's non-invasive prenatal testing (NIPT) market expansion.

Growth Drivers for the Australia Non-Invasive Prenatal Testing Market

Public Awareness Campaigns: In Australia, public awareness initiatives have been essential in promoting the use of non-invasive prenatal testing (NIPT). Expectant parents are learning the value of early prenatal screening for genetic disorders including trisomy and Down syndrome through a variety of educational initiatives, such as media campaigns, outreach to healthcare providers, and instructional materials. These programs demonstrate NIPT's accuracy, safety, and dependability, especially in contrast to more conventional intrusive testing methods. For peace of mind and early identification of any fetal anomalies, more parents are opting to get NIPT. The demand for NIPT services in Australia has expanded dramatically as a result of this greater awareness and the rising emphasis on preventative healthcare.

Better Access in Rural Areas: Non-invasive prenatal testing (NIPT) is now much more accessible in Australia's rural and regional locations because of expanding healthcare infrastructure, which has fueled expansion across the country. Advanced prenatal testing has historically been more widely available in cities, leaving those in rural regions with few alternatives. However, NIPT is now more widely accessible nationwide due to continuous efforts to upgrade medical facilities and telemedicine services. By ensuring that more pregnant mothers, wherever they may be, have access to timely and precise prenatal diagnostics, this expansion promotes the wider use of NIPT services and enhances maternal health outcomes in general.

Advancements in Screening Technology: The extensive use of non-invasive prenatal testing (NIPT) in Australia can be attributed in large part to technological advancements. Important advancements like bioinformatics and next-generation sequencing (NGS) have improved NIPT's accuracy and dependability, giving it a better choice for pregnant parents. The advantages of NIPT in prenatal care are becoming more generally acknowledged as the technology advances, which is driving up its usage for early genetic screening throughout Australia.

Challenges in the Australia Non-Invasive Prenatal Testing Market

High Cost of Testing: For many Australian pregnant parents, especially those without private health insurance, the high expense of non-invasive prenatal testing (NIPT) continues to be a major obstacle. The cost of NIPT may make this cutting-edge prenatal screening tool unavailable to people with lower incomes or those receiving public healthcare. Some parents may choose to avoid testing or choose less precise, intrusive alternatives as a consequence. Making NIPT more widely available requires initiatives to lower prices or expand insurance coverage.

Awareness Gaps in Remote Areas: Even though non-invasive prenatal testing (NIPT) is becoming more widely known in Australia, there are still knowledge gaps in rural and isolated locations. Due to factors including geographic isolation, a lack of public health education, and a lack of healthcare resources, access to information regarding NIPT and its advantages is frequently restricted in these areas. By filling up these knowledge gaps, telemedicine, mobile health services, and focused outreach can help guarantee that all pregnant parents have fair access to NIPT.

Key Attributes

Report Attribute	Details
No. of Pages	200
Forecast Period	2024 - 2033
Estimated Market Value (USD) in 2024	$71.4 Million
Forecasted Market Value (USD) by 2033	$218.3 Million
Compound Annual Growth Rate	13.2%
Regions Covered	Australia

Key Topics Covered
1. Introduction
2. Research Methodology
3. Executive Summary
4. Market Dynamics
4.1 Growth Drivers
4.2 Challenges
5. Australia Non-Invasive Prenatal Testing Market
6. Market Share Analysis
6.1 Component
6.2 Application
6.3 End User
7. Component
7.1 Instruments
7.2 Kits and Reagents
7.3 Services
8. Application
8.1 Down Syndrome (trisomy 21)
8.2 Edwards Syndrome (trisomy 18)
8.3 Patau Syndrome (trisomy 13)
8.4 Turner Syndrome
8.5 Other Applications
9. End User
9.1 Hospitals
9.2 Diagnostic Labs
10. Porter's Five Analysis
10.1 Bargaining Power of Buyers
10.2 Bargaining Power of Suppliers
10.3 Degree of Rivalry
10.4 Threat of New Entrants
10.5 Threat of Substitutes
11. SWOT Analysis
11.1 Strength
11.2 Weakness
11.3 Opportunity
11.4 Threat
12. Key Players Analysis

• Eurofins Scientific
• F. Hoffmann-La Roche Ltd.
• Invitae Corporation
• Illumina Inc.
• Natera Inc.
• Centogene N.V.
• Qiagen

For more information about this report visit

About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Attachment

• Australian Non-Invasive Prenatal Testing Market

CONTACT: CONTACT: Laura Wood,Senior Press Manager... For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

MENAFN05112025004107003653ID1110297995